Skip to main content
Smart Investors Daily
ED

OTC · EDXC

Endexx Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Up+$0.00 (+0.00%)

Updated Sep 17, 2026, 10:34 AM

SID Score

2.3/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
772.55K
P/E ratio
-0.07
Dividend yield
0.00%
52-week range
$0.00 – $0.01
Volume
1.22M
Avg. volume
564.04K

Price performance

EDXC price history

1M range · 0 trading sessions · Daily adjusted prices

EDXC does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest EDXC news

The latest Smart Investors Daily articles mentioning EDXC.

EDXC research

Overview

Company profile and research snapshot.

Company profile

ENDEXX CORP

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

Investing.com · Jul 16, 2024

Endexx Corp announces leadership shakeup - Investing.com

Endexx Corp, a Nevada-based business services company, has announced significant changes in its executive leadership. Todd Davis has resigned as the sole officer and Chairman of the Board, but will continue to serve as a board member and CEO of the company's subsidiary, CBD Unlimited, Inc. The Board of Directors has taken on the responsibilities of CEO and CFO, and has appointed Brad Listermann as the interim executive officer.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.